Platkin Co-Leads Multistate Coalition Asking FDA to Expand Access to Medication Abortion

New Jersey Attorney General Matthew J. Platkin and the attorneys general of California, Massachusetts, and New York today filed a petition requesting that the U.S. Food and Drug Administration (FDA) eliminate unnecessary restrictions on the abortion medication mifepristone.

Attorney General Platkin and the coalition argue that mifepristone has proven overwhelmingly safe and effective in the 25 years since it was first approved by the FDA, and that the agency’s current Risk Evaluation and Mitigation Strategy (REMS) program imposes burdensome restrictions on access to medication abortion while not meaningfully improving patient safety.

Citizen Petition 

The petition comes as the FDA undertakes a full review of mifepristone labeling requirements at the direction of Secretary of Health…